Gender and age differences in the recurrence of sickness absence due to common mental disorders: a longitudinal study by Koopmans, Petra C et al.
RESEARCH ARTICLE Open Access
Gender and age differences in the recurrence
of sickness absence due to common mental
disorders: a longitudinal study
Petra C Koopmans
1,2*, Corné AM Roelen
3,2, Ute Bültmann
2, Rob Hoedeman
4,2, Jac JL van der Klink
2,
Johan W Groothoff
2
Abstract
Background: Common mental disorders (CMDs) are an important cause of sickness absence and long-term work
disability. Although CMDs are known to have high recurrence rates, little is known about the recurrence of sickness
absence due to CMDs. The aim of this study was to investigate the recurrence of sickness absence due to CMDs,
including distress, adjustment disorders, depressive disorders and anxiety disorders, according to age, in male and
female employees in the Netherlands.
Methods: Data on sickness absence episodes due to CMDs were obtained for 137,172 employees working in the
Dutch Post and Telecommunication companies between 2001 and 2007. The incidence density (ID) and recurrence
density (RD) of sickness absence due to CMDs was calculated per 1000 person-years in men and women in the
age-groups of < 35 years, 35-44 years, 45-54 years, and ≥ 55 years.
Results: The ID of one episode of CMDs sickness absence was 25.0 per 1000 person-years, and the RD was 76.7
per 1000 person-years. Sickness absence due to psychiatric disorders (anxiety and depression) does not have a
higher recurrence density of sickness absence due to any CMDs as compared to stress-related disorders (distress
and adjustment disorders): 81.6 versus 76.0 per 1000 person-years. The ID of sickness absence due to CMDs was
higher in women than in men, but the RD was similar. Recurrences were more frequent in women < 35 years and
in women between 35 and 44 years of age. We observed no differences between age groups in men. Recurrences
among employees with recurrent episodes occurred within 3 years in 90% of cases and the median time-to-onset
of recurrence was 11 (10-13) months in men and 10 (9-12) months in women.
Conclusions: Employees who have been absent from work due to CMDs are at increased risk of recurrent sickness
absence due to CMDs and should be monitored after they return to work. The RD was similar in men and in
women. In women < 45 years the RD was higher than in women ≥ 45 years. In men no age differences were
observed.
Background
Mental disorders are common in the general population,
particularly among women between 25 and 45 years of
age [1-4], and there is a high risk of recurrence. For
depressive disorders, recurrences have been reported in
50-85% of patients, and very few demographic or clinical
characteristics have been found to predict a recurrence
after recovery from a major depressive disorder [5,6].
Recently, it has been reported that the more recurrences
of depressive episodes, the higher the likelihood of a
subsequent episode [7]. Depressive episodes remit but
may leave psychological scars, such as negative cognitive
patterns which were not present prior to the episode
[8]. Such cognitive scars can also be caused by anxiety
disorders, and may contribute to the recurrence of men-
tal disorders [9-11]. Patients with two or more lifetime
episodes of mental disorders, are at risk for long-term
pharmacotherapy, especially if they have comorbid dis-
orders, report psychosocial stressors, poor symptom
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cotherapy, a chronic clinical course with low rates of
recovery and a high probability of recurrence is found
in the majority of patients suffering from anxiety disor-
ders [13,14].
Common mental disorders (CMDs) include criteria-
based psychiatric disorders, mostly mild to moderate
depressive disorders and anxiety disorders, as well as
‘subtreshhold’syndromes such as distress and adjustment
disorders. CMDs are the second most frequent cause of
sickness absence after musculoskeletal disorders [15-19].
In Scandinavian countries, the incidence of sickness
absence due to CMDs is increasing when compared to
sickness absence due to other diagnoses [17,18]. In the
Netherlands a quadratic trend was observed: the 12-
month incidence of sickness absence due to CMDs was
2.2% in 2001, increased to 2.7% in 2004 and decreased
thereafter to 2.0% in 2007 [19]. Sickness absence due to
CMDs has been associated with long-term work disabil-
ity resulting in high social and economic costs [20-25].
Research on sickness absence among employees with
psychiatric diagnoses has focused on the duration of the
episodes of sickness absence and the risk of a disability
pension. Vaez et al. found that 65% of those who
returned to work after being absent due to mental disor-
ders had high levels of all cause sickness absence in the
following three years [21]. We assume that there is a
high risk of recurrent sickness absence due to CMDs in
employees who have returned to work after a previous
episode of absence due to CMDs.
Although mental disorders are known to have high
recurrence rates [5,6,14], the recurrence of sickness
absence due to CMDs by gender and age has not been
investigated yet. With regard to gender and sickness
absence due to mental disorders contradictory findings
are reported [26]. Women show higher sickness absence
and are more frequently sick-listed due to mental disor-
ders than men [27]. Although mental disorders are
more common among women, sickness absence seems
to be longer among male employees with mental disor-
ders than among female employees with mental disor-
ders [28,29]. However, Koopmans et al. [30] found a
longer duration of absence due to depression in women
than in men. Men and women had an equal duration
until return to work (RTW), but women did report a
longer time until lasting return to work than men after
a long-term absence due to mental disorders [31]. Last-
ing return to work was defined as return to work with-
out recurrence during the period in which the study was
conducted. In the Netherlands the incidence of CMDs is
higher in people aged 18-45 years than in those older
than 45 years [2,32-34]. In the present study, the recur-
rence of sickness absence due to CMD will be exam-
ined, thereby stratifying by gender and age. In addition,
the time-to-onset of recurrent episodes of sickness
absence due to CMDs will be investigated. We hypothe-
size that the risk of recurrent sickness absence due to
CMDs increases after a previous episode of sickness
absence due to CMDs. We further hypothesize that
women and employees < 45 years have a higher risk of
recurrence than men and employees > 45 years.
Methods
Study population
This dynamic population study included employees who
worked in the Dutch Post and Telecommunication com-
panies in the period from 2001 to 2007. Employees were
included on January 1st 2001; employees who started
working later were included on the date they entered
employment, and employees who resigned or retired
during the study period were censored on the day they
left employment. Employees who reached the one-year
sickness absence date were also censored on that date.
The total population consisted of 137,172 employees
(62% men and 38% women), with a total of 363,461 per-
son-years at risk. Approximately 70% of the employees
worked as post sorters, postmen and post officers in the
Post companies. The remainder of 30% worked in the
Telecommunication companies, and were charged with
installing and maintaining telephone, telefax and inter-
net systems or worked in the call center or client ser-
vices. Many employees, especially those in the Post
companies, worked on a temporary basis. Both compa-
nies had a high turnover. Of the 67,316 employees who
were included in the study on January 1
st, 2001, 51,280
resigned or were discharged and right censored on the
date they left employment, or their company left our
occupational health department. A total of 69,856
employees started working for the Post and Telecom-
munication companies after January 1
st, 2001 and were
included on the date they entered employment. Of
those 48,231 left their job again or their company left
our occupational health department before the end of
the study period and these employees were right cen-
sored on the leaving date.
Ethical approval
The Medical Ethics Committee of the University Medi-
cal Center in Groningen informed us that ethical
approval was not required because the data were ana-
lysed in retrospect at group level.
Sickness absence in the Netherlands
Since 2004 most employers pay 100% of the income of
an employee in the first year of sick leave and 70% in
the second year. In general, episodes of sickness absence
lasting for one or two weeks are self-certified. Employ-
ees in the Post and Telecommunication companies had
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week of sickness absence for medical certification. OPs
certify mental disorders according to the 10
th Interna-
tional Classification of Diseases (ICD-10) [35]. The
employer is responsible for the return to work process
and the OP gives advice about the possibilities of return
to work and work adjustment. The OP updates medical,
social and vocational data in follow-up consults every
four to six weeks, and guides sick-listed employees to
return to work. Before 2004, a disability pension was
granted after one year of sickness absence, but since
2004 a disability pension is granted after two years of
sickness absence. For uniformity we applied the more
conservative one year limit throughout the entire study
period from 2001 to 2007, and censored the data of
employees who were absent for longer than 365 days.
Data on episodes of medically certified sickness
absence between January 1
st, 2001 and December 31
st,
2007 were retrieved from the records of ArboNed Occu-
pational Health Services. We wanted to exclude employ-
ees who were absent at the start of the study, because
these employees cannot be considered incident cases.
Therefore, employees who were absent for more than
13 weeks due to sickness on 1 January 2001 were
excluded, irrespective of the cause of the sickness
absence. We choose this period, because employees who
were absent for more than 13 weeks have to be reported
to the social security agency in the Netherlands at that
time and they were monitored by this agency during the
course of their illness. We excluded 4158 employees due
to this criterion. About 19% of them had common men-
tal disorders. Sickness absence due to CMDs was medi-
cally certified as follows: distress (ICD-10 code R45),
adjustment disorders (ICD-10 code F43), mild to moder-
ate depressive disorders (ICD-10 codes F32.0 and F32.1),
and anxiety disorders (ICD-10 codes F40.0, F40.1, F40.2,
F41.0, F41.1, F41.2, and F41.3). We stratified the results
into stress-related disorders (distress and adjustment
disorders) and psychiatric disorders (depressive disor-
ders and anxiety disorders).
Statistical analysis
The first sickness absence episode due to CMD since
January 1
st,2 0 0 1o rt h ed a t eo fe n t e r i n ge m p l o y m e n t
was regarded as the index episode in this study. The
incidence density (ID) of index episodes was calculated
by dividing the number of employees with a first epi-
sode of sickness absence due to CMDs between 2001
and 2007 by the person-years of the total population at
risk. The recurrence density (RD) of sickness absence
due to CMDs was computed by dividing the number of
employees with recurrent episodes by the person-years
in the sub-population of men and women with a pre-
vious episode of sickness absence due to CMDs in the
different age groups. A recurrence was defined as the
start of a new episode of absence due to CMDs after a
recovery period of at least 28 days. We choose for this
criterion, because in the Netherlands absences succeed-
ing each other with an interval of less than 28 days are
summed, in order to determine the qualifying period
until work disability. The person-years at risk for ID
were based on the total time of employment in the
observation period. The person-years at risk for RD
were based on the total time of employment in the
observation period minus the time before the index epi-
sode of sickness absence due to CMDs.
Figure 1 shows the periods at risk for incidence and
recurrence in different situations. In situation a) there is
one episode of sickness absence due to CMDs and no
recurrent episode. In that case, the total period of
employment between January 1
st, 2001 and December
31
st, 2007 contributed to the person-years for the calcu-
lation of the ID. The person-years for the RD are
counted from the beginning of the index episode of
sickness absence due to CMDs until the end of the
employment period. In situation b) a second absence
due to CMDs occurs > 28 days after return to work. We
define this situation as recurrent sickness absence due to
CMDs. In situation c) there is a second episode of sick-
ness absence due to CMDs within 28 days after return
to work, which is not counted as a recurrence, because
the Dutch social security legislation considers this situa-
tion as a connected episode of sickness absence. In the
example, the employee is employed during the entire
period. The person-years for the ID amount to seven
years, and the person-years for the RD start at the
beginning of the index episode of sickness absence due
to CMDs. In situation d) there is an episode of sickness
absence due to CMDs lasting more than 365 days. The
person-years for the ID and the RD are counted until
one year of sickness absence.
The ID and the RD of sickness absence due to CMDs
were assessed in men and women in the age-groups of
< 35 years, 35-44 years, 45-54 years, and ≥ 55 years.
The median time-to-onset of a recurrent episode of
sickness absence due to CMDs was computed with
Kaplan-Meier survival curves. The survival curves for
the age-groups were compared using the logrank test,
based on the null hypothesis that the survival curves in
the age-groups are the same [36].
Results
Descriptives of the population
Between 2001 and 2007, 8,951 employees (58% men and
42% women) had a total of 10,921 episodes of sickness
absence episodes due to CMDs: 4,248 (39%) episodes
with distress, 5,219 (48%) with adjustment disorders,
1,025 (9%) with depressive disorders and 429 (4%) with
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ees (82%) had one episode of sickness absence due to
CMDs; 1,274 (14%) had two episodes, 228 (3%) had
three episodes and 70 (1%) had more than three epi-
sodes. The ID of sickness absence due to CMDs in the
total population was 25.0 per 1000 person-years (95%
confidence interval [CI] 24.5-25.5) between 2001 and
2007. After an episode of absence from work due to
CMDs, the RD of sickness absence due to CMDs was
76.7 per 1000 person-years (95% CI 72.9-80.5). Of those
with a recurrence, 90% experienced the recurrence
within 3 years.
In the total study population the ID of stress-related
disorders was 22.4 (95% CI 21.9-22.9) per 1000
person-years, which was higher than the ID for
psychiatric disorders (3.7; 95% CI 3.5-3.9) per 1000
person-years. Table 1 shows the IDs stratified by age
for men and Table 2 for women. After the index
episode, stress-related disorders had an RD of 76.0
(95% CI 71.9-80.0) per 1000 person-years as compared
to an RD of 81.6 (95% CI 70.8-92.5) per 100 person-
years for psychiatric disorders. The RDs stratified for
age are shown in Tables 1 and 2. In psychiatric disor-
ders, the duration of a recurrent episode (72 days;95%
CI 53-91 days) is shorter than the duration of
the index episode (168 days; 95% CI 156-180) with
p < 0.001, whereas in stress-related disorders the
duration of a recurrent episode (51 days; 95% CI
46-56) did not differ from the duration of the index
episode (53 days; 95% CI 51-55) with p = 0.221. The
median duration until recurrence is 11 months for
stress-related disorders (95% CI = 10-12 months) and
11 months (95% CI = 9-13 months) for psychiatric
disorders (logrank test p = 0.913).
Figure 1 Calculation of incidence density and recurrence density of sickness absence due to common mental disorders.
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As shown in Table 1, the median duration of sickness
absence due to CMDs was 57 days (95% CI 54-60) in men,
and sickness absence due to stress related disorders was of
shorter duration than sickness absence due to psychiatric
disorders. The ID of sickness absence due to stress-related
disorders was 19.7 (95% CI 19.1-20.2) per 1000 person-
years and the RD was 74.4 (95% CI 72.9-76.0) per 1000
person-years in men. The ID of sickness absence due to
psychiatric disorders was 3.0 (95% CI 2.8-3.2) per 1000
person-years and the RD was 83.8 (95% CI 71.9-95.7) in
men. The RD due to any type of CMDs after stress related
and after psychiatric disorders did not differ significantly,
because the 95% confidence intervals overlap. Recurrences
were of shorter median duration than the index episode
(48 days; 95% CI 43-53 days) but the survival curve for
recurrent sickness absence did not differ significantly from
the curve for the index episode (logrank test p = 0.172).
The ID of stress-related and psychiatric disorders was
lower in men < 35 years as compared to older men. The
RD of sickness absence due to CMDs was not associated
with age (logrank test p = 0.636), and the difference in
time-to-onset of recurrence in men with a recurrence was
not significant across age groups (logrank test p = 0.117).
The median time-to-onset of recurrence in men was 11
months (95 CI = 10-13 months).
As shown in Table 2, the (median duration of sickness
a b s e n c ed u et oC M D sw a s6 7d a y s( 9 5 %C I6 3 - 7 1 )i n
women and the shortest duration was found in the
age-group of < 35 years (logrank test p < 0.001). As in
men, sickness absence due to stress-related disorders was
of shorter duration than sickness absence due to psychia-
tric disorders. The ID of sickness absence due to stress-
related disorders was 27.8 (95% CI 26.8-28.7) per 1000
person-years and the RD was 78.4 (95% CI 75.9-80.9) per
1000 person-years. The ID of sickness absence due to psy-
chiatric disorders was 5.2 (95% CI 4.7-5.6) per 1000 per-
son-years and the RD was 78.9 (95% CI 64.1-93.7) per
1000 person-years. The RD due to any type of CMDs after
stress related and after psychiatric disorders did not differ
significantly, because the 95% confidence intervals overlap.
The RD of sickness absence due to CMDs in women
decreased with age (logrank test p = 0.004). Recurrences
were of shorter median duration compared to index
episode (62 days; 95% CI 55-69 days) but, as in men, the
survival curve for recurrences did not differ from the
curve for the index episode (logrank test p = 0.102).
Recurrent sickness absence after stress-related or psychia-
tric disorders was most common in women < 35 years and
between 35 and 44 years. The median time-to-onset of
recurrence in women was 10 months (95% CI = 9-12
months). The difference in time-to-onset of recurrence in
women with a recurrence was not significant across
age-groups (logrank test p = 0.667).
Men had a lower ID of sickness absence due to CMDs
than women (21.8 per 1000 person-years versus 31.5 per
Table 1 Incidence and recurrence density of sickness absence due to common mental disorders by type of mental
disorder in men of different ages
Index episode Recurrent episodes Median time-to-onset
recurrence in
months (95% CI) ||
Median duration Median duration
N in days
(95%CI)
ID (95%CI)† N in days
(95%CI)
ID (95%CI)†
< 35 years 783 37 (33-41) 10.0 (9.3-10.8) 93 36 (18-54) 75.7 (61.8-89.6) 8 (3-13)
35 - 44 years 1554 53 (49-57) 22.2 (21.0-23.3) 270 47 (39-55) 75.0 (70.3-79.7) 12 (10-15)
45 - 54 years 1903 54 (50-58) 24.0 (23.0-25.1) 362 49 (40-58) 74.3 (70.8-77.8) 12 (10-14)
≥ 55 years 464 52 (46-58) 23.4 (21.6-25.2) 86 42 (27-57) 72.1 (58.1-86.0) 10 (8-12)
Total men stress 4704 49 (47-51) 19.7 (19.1-20.2) 811 46 (41-51) 74.4 (72.9-76.0) 11 (10-13)
< 35 years 127 153 (94-212) 1.6 (1.3-1.9) 14 25 (0-110) 70.0 (0-152.0) 14 (8-20)
35 - 44 years 257 168 (141-195) 3.6 (3.1-4.1) 48 81 (36-126) 97.0 (58.0-136.0) 8 (0-15)
45 - 54 years 286 178 (144-212) 3.7 (3.3-4.1) 55 103 (33-173) 80.1 (54.5-105.6) 14 (9-19)
≥ 55 years 53 171 (100-242) 3.0 (2.4-3.6) 9 31 (2-60) 73.9 (0-212.1) 8 (1-15)
Total men psychiatric 723 168 (150-186) 3.0 (2.8-3.2) 126 68 (39-97) 83.8 (71.9-95.7) 12 (8-15)
Total men CMD 34,603 57 (54-60) 21.8 (21.2-22.4) 937 48 (43-53) 75.6 (70.7-80.4) 11 (10-13)
† per 1000 person-years
|| in those with a recurrence
ID = incidence density
RD = recurrence density
CI = confidence interval
The table shows the age-distribution and the median duration (in days), ID and RD with their 95% CIs of sickness absence due to CMDs as well as the time-to-
onset of recurrent sickness absence due to CMDs in months.
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to CMDs in men (75.6 per 1000 person-years) was
almost the same as in women (78.5 per 1000 person
years) with a logrank test result of p = 0.360.
Discussion
The findings of this study show that after an episode
of absence from work due to CMDs, the risk of recur-
rent sickness absence due to CMDs increases. Stress-
related disorders had a higher incidence than psychia-
tric disorders, but the recurrence of CMD after stress-
related disorders was not different from the recurrence
of CMD after psychiatric disorders. Although sickness
absence due to CMDs was more common in women,
t h e r ew e r en og e n d e rd i f f e r e n c e si nt h er e c u r r e n c eo f
sickness absence due to CMDs. Recurrences were
more frequent in women < 35 years and in women
between 35 and 44 years. In men, we observed no dif-
ference in recurrence by age. Recurrent episodes of
sickness absence due to CMDs were of shorter dura-
tion in men, but the median time-to-onset of a recur-
rence was comparable among women and men, and
did not differ across age-groups.
In all, the results of this study confirm our hypothesis
that the risk of recurrent sickness absence due to CMDs
increases after a previous episode of sickness absence
due to CMDs. The results indicate that recurrent
episodes after sickness absence due to psychiatric CMDs
were shorter than the index episode. Perhaps employees
who have had a previous sickness absence episode due
to psychiatric CMDs recognize their complaints and
seek help at an earlier stage or rely on their previous
experiences of returning to work after mental health
complaints. It should be noted that in the present study
the first episode of sickness absence due to CMDs since
January 1
st, 2001 was regarded as the index episode,
regardless of any sickness absence before that date.
Women have a higher risk of CMDs than men
[2,32-34], but gender was not related to the recurrence
of major depressive disorder [6,37]. This contrasts the
findings of Mueller et al., who reported that women had
ah i g h e rr e c u r r e n c eo fam a j o rd e p r e s s i v ed i s o r d e rt h a n
m e n[ 5 ] .I no u rs t u d yp o p u l a t i o n ,w o m e nh a dl o n g e r
episodes of sickness absence due to CMD than men and
were censored more often at 365 days of sickness
absence. When more men than women return to the
population at risk, the incidence of recurrent sickness
absence will be relatively higher among men. A recent
meta-analysis showed conflicting results with regard to
gender differences in return to work in employees with
episodes of poor mental health [26]. According to De
Rijk et al. [31], women did report a longer time until
lasting return to work than men after a long-term
absence due to mental disorders.
Table 2 Incidence and recurrence density of sickness absence due to common mental disorders by type of mental
disorder in women of different ages
Index episode Recurrent episodes Median time-to-onset
recurrence in months
(95% CI) ||
Median duration Median duration
N in days
(95%CI)
ID (95%CI)† N in days
(95%CI)
ID (95%CI)†
< 35 years 1016 49 (43-55) 24.3 (22.7-25.9) 151 62 (49-75) 94.4 (82.5-106.3) 9 (6-11)
35 - 44 years 1319 56 (51-61) 32.2 (30.5-34.0) 236 62 (47-77) 79.6 (73.7-85.5) 11 (9-13)
45 - 54 years 783 61 (54-68) 26.3 (24.6-28.1) 135 56 (42-70) 69.0 (60.6-77.3) 10 (7-13)
≥ 55 years 180 65 (48-82) 26.4 (23.0-29.9) 20 42 (0-129) 51.2 (15.3-87.2) 14 (13-15)
Total women stress 3298 56 (53-59) 27.8 (26.8-28.7) 542 60 (51-69) 78.4 (75.9-80.9) 11 (9-12)
< 35 years 212 153 (125-181) 5.1 (4.4-5.9) 28 73 (17-129) 90.4 (30.2-150.6) 9 (7-12)
35 - 44 years 242 161 (138-184) 5.8 (5.0-6.5) 44 85 (49-121) 90.3 (52.1-128.5) 10 (8-11)
45 - 54 years 136 217 (173-261) 4.9 (4.1-5.7) 18 67 (17-117) 53.5 (10.9-96.1) 11 (0-22)
≥ 55 years 22 248 (118-378) 3.2 (2.0-4.4) 3 59 (9-109) 66.1 (0-417.2) 12 (0-29)
Total women psychiatric 612 168 (151-185) 5.2 (4.7-5.6) 93 73 (53-93) 78.9 (64.1-93.7) 10 (8-12)
Total women CMD 18,026 67 (63-71) 31.5 (30.5-32.5) 635 62 (55-69) 78.5 (72.4-84.6) 10 (9-12)
† per 1000 person-years
|| in those with a recurrence
ID = incidence density
RD = recurrence density
CI = confidence interval
The table shows the age-distribution and the median duration (in days), ID and RD with their 95% CIs of sickness absence due to CMDs as well as the time-to-
onset of recurrent sickness absence due to CMDs in months.
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absence due to CMDs [2,32-34]. We hypothesized that
employees younger than 45 years have a higher risk of
recurrent sickness absence due to CMDs than employ-
ees > 45 years. Our results demonstrate that the risks of
recurrence in men do not differ significantly across the
age groups. However, women under the age of 35 and
between 35-44 years had higher recurrence of sickness
absence due to CMDs than women between 45-54 years
and ≥ 55 years of age. Nieuwenhuijsen et al. reported a
poorer recovery from mental disorders in employees
over 50 years of age [38]. Women ≥ 45 years with a
poorer recovery might have been absent for a longer
period of time and therefore had either a shorter risk
period for a recurrence or a higher risk of being cen-
sored after 365 days of absence from work due to
CMDs. The risk of recurrence in the oldest age groups
may also have been underestimated, because older
employees are more likely to resign or to be discharged,
once long-term absent [39].
We found no significant difference across age-groups
in the time-to-onset of recurrent sickness absence due
to CMDs. Of the employees who had a recurrence, 90%
experienced the recurrence within 3 years.
Strengths and limitations
A strength of the present study is the use of sick-leave
certificates issued by the OPs instead of self-reported
complaints by the employees. However, the validity of
psychiatric diagnoses on sickness absence certificates is
a subject of ongoing scientific debate [17]. In a pilot
study of 8,500 post sorters working for the post compa-
nies, all 546 employees who reported sick in 2003 con-
sulted an OP and a psychiatrist [40]. Between OPs and
psychiatrists, an agreement of 81% was found with
regard to the group diagnosis of CMDs, confirming the
results reported by O’Niell et al.[41]. However, the OPs
frequently diagnosed distress or adjustment disorders,
whereas the psychiatrists more often diagnosed depres-
sive disorders and anxiety disorders.
The incidence of sickness absence due to CMDs was
lower in our study population (25.0 per 1000 person-
years) than the incidence of depressive and anxiety dis-
orders in the general population in the Netherlands,
which was 56.8 per 1000 person-years in 1999 [2]. The
study population may be healthier than the general
population and therefore have a lower incidence of
depressive and anxiety disorders. It is also possible that
employees with mild to moderate mental problems do
not report sick. Depression and anxiety are known to be
associated with presenteeism, i.e. being at work, but not
able to perform adequately [4,5,42]. Alternatively,
employees with mental disorders often present somato-
form complaints [43,44], and in primary care it is not
usual to ask detailed questions to discover underlying
mental disorders [45].
Another limitation concerns the lack of data on
co-morbidity. The sick-leave certificate only contained
one diagnosis. Depression with comorbid disorders has
been reported to have a higher likelihood of recurrence
[15]. We are also not aware as to whether the diagnoses
changed over time, which is a common shortcoming in
studies of this type [17]. It may be that the RD person-
years are over-estimated, because we used the time
from the start of the index episode due to CMDs
instead of the recovery date, whereas an employee who
is on sick-leave is actually not at risk for recurrent sick-
ness absence. However, the end date of an episode of
sickness absence is less reliable than the start date,
because episodes of sickness absence can end due to
several reasons: return to work, leaving employment,
the end of the company’s contract with the occupational
health service, administrative closure of the case after
one year of sickness absence, or a change in the labour
contract. Over-estimation of the person-years at risk in
the denominator may have resulted in an under-estima-
tion of risk of recurrence. The risk of recurrence may
also have been under-estimated because of the high
turnover in the study population. Employees who have
been absent due to sickness are more likely to resign or
to be discharged than those who have never been
absent due to sickness [39]. The generous sick leave
entitlements in the Netherlands may have influenced
the tendency to report sick due to mental disorders and
also the risk of recurrent sickness absence. Therefore,
the results may not be generalized to other countries
just like that.
The recurrence risk of sickness absence due to CMDs
might in part be due to confounding by indication. If an
employee is absent from work due to CMDs, the likeli-
hood to be diagnosed CMD once absent from work a
second time is much higher than to be diagnosed CMD
a first time. This may have resulted in an over-estima-
tion of RD due to CMDs.
The results of our studies of the Post and Telecom-
munications companies cannot be generalized to the
entire working population in the Netherlands, because it
has been reported that there are differences between
companies in sickness absence policies and cultures
[46]. However, in our population there are a consider-
able number of employees who carry out various types
of work (heavy physical labour, back-office, technique,
sales, IT, and executive functions) in a nationwide
spread of establishments.
In conclusion, given the high recurrence rate of
sickness absence due to CMDs and the median time of
10-11 months until recurrence, employees should be
monitored after they have returned to work following
Koopmans et al. BMC Public Health 2010, 10:426
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Page 7 of 9sickness absence due to CMDs to prevent relapse. In
particular, women under 35 years and between 35 and
44 years who are at high risk of recurrence should be
monitored closely and offered regular preventive con-
sultations. Future research should investigate the
effects of interventions to prevent relapse of sickness
absence due to CMDs or to facilitate sustainable
return to work.
Conclusions
Employees who have been absent from work due to
CMDs are at increased risk of recurrent sickness
absence due to CMDs and should be monitored after
they return to work. Women under 35 years of age and
between 35 and 44 years of age have a high risk of
recurrence. However, because the risk of recurrence in
women in other age-groups and men is also high, we
recommend relapse prevention consultations for men
and women in all age-groups.
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